Cost Efficiency and Cost Effectiveness of Cataract Surgery at the Malaysian Ministry of Health Ophthalmic Services
Tóm tắt
Purpose: To determine the cost efficiency and to compare the cost effectiveness of conventional extracapsular cataract surgery (ECCE) and phacoemulsification at three hospitals of the Malaysian Ministry of Health (MOH). Methods: Patient demography, pre-operative visual acuity, intra-operative complications, post-operative complications and post-operative visual acuity were recorded for two hundred and forty seven of the 400 patients who underwent cataract surgery during a 2-week period. The cost of surgery, which included capital, staff and overhead, and patient care consumable costs were assessed prospectively in 8 randomly sampled patients over a 3-month period. Cost efficiency refers to cost per cataract surgery. Cost effectiveness refers to cost per successful cataract surgery. This is estimated by the ratio of cost efficiency to the proportion of successful cataract surgery. Successful surgery was defined as best-corrected visual acuity (BCVA) of better than 6/12 at 3 months post-operatively. Results: Proportion of patients who had post-operative visual acuity of 6/12 or better was higher in phacoemulsification group (94%) than in the ECCE group (81%). Conventional extracapsular cataract surgery with intraocular lens implant costs RM3442 (USD905.79) and phacoemulsification with intraocular lens implant costs RM4288 (USD 1128.42). Discussion: There was no significant difference in cost effectiveness between ECCE and phacoemulsification. The cost of cataract surgery in the MOH hospital was found to be high due to the high overhead costs.
Tài liệu tham khảo
Phillips C, Palfrey C, Thomas P (eds) Evaluating health and social care. MacMillan Press, London, 1994.
Tugwell P, Benneett KJ, Sackett DL, Haynes RB. The measurement interactive loop: a framework for the critical appraisal of need, benefit and costs of health interventions. J Chronic Dis 1985: 339–51.
Drummond MF, Stoddart GL, Torrance GW (eds) Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press, 1987.
Zainal M, Ismail SM, Ropilah AR, Elias H, Arumugam G, Alias D, et al. Estimates from the National Eye Survey, Ministry of Health of Malaysia, 1996.
Javitt JC, Venkataswamy G, Sommer A. The economic and social impact of restoring sight. In: Henkind P (ed) ACTA: 24th International Congress of Ophthalmology. Philadelphia, PA: JB Lippincott, 1983: 1308–1311.
Drummond MF. Economic aspects of cataract blindness. In: Kupfer C, Gillen T (eds) World blindness and its prevention. Bethesda, MD: International Agency of the Prevention of Blindness, 1986.
Ellwein LB, Lepkowski JM, Thulasiraj RD, Brilliant GE. The cost effectiveness of strategies to reduce barriers to cataract surgery. Int. Ophthalmol. 1991; 15: 175–183.
Javitt JC. Cataract. In: Jamison DT, Mosley WH, Measham AR, Bobadilla JL (eds) Disease control priorities in developing countries. New York, NY: Oxford University Press, 1993: 635–645.
Javitt JC. The cost-effectiveness of restoring sight. Arch Ophthalmol 1993; 111: 1615.
Singh AJ, Paul Garner, Floyud K. Cost-effectiveness of public-funded options for cataract surgery in Mysore, India. Lancet. 2000 Jan 15; 355(9199): 180–4.
Asimakis P, Coster DJ, Lewis DJ. Cost-effectiveness of cataract surgery. Aust N Z J Ophthalmol. 1996 Nov; 24(4): 319–25.
Richardson AW, Gafni A. Treatment of capital costs in evaluating health acre programmes. Cost Management 1983; 58: 26–30.
Gold MR, Siegel JE, Russel LB, Weinstein MC (eds) Cost effectiveness in health and medicine. Oxford University Press, 1996.
Chaudhary M, Stearns SC. Estimating confidence intervals for cost effectiveness ratios. Stat Med 1996; 15: 1447–1458.
Steinberg EP, Tielsch JM, Schein OD, Javitt JC, Sharkey P, Cassard SD, et al. The VF 14-An index of functional impairment in patients with cataract. Arch Ophthalmol 1994; 112: 630–638.